Accueil > Scientific Advisory Board
Scientific Advisory Board
Composed of leading scientists in the field of cancer research, the Scientific Advisory Board assists the direction of the CRCL on the scientific and strategic orientations of the center. It is particularly involved in the preparatory phase of the evaluation CRCL’s evaluation process and delivers an opinion on the scientific projects carried out by the research teams of the center.
Members of the Scientific Advisory Board

Dr Scott Lowe
Memorial Sloan Kettering Cancer Center, Howard Hughes Medical institute, New-York, USA
Pr. Elaine Fuchs
Howard Hughes Medical Institute, The Rockefeller University, New-York, USA

Pr. Eric Solary
Université Paris-Saclay, Institut Gustave Roussy, Paris, France

Dr. Martin McMahon
Huntsman Cancer Institute, University of Utah, USA

Pr. Elisabeth de Vries
University Medical Center Groningen, Netherlands

Pr. Nada Jabado
McGill University, Canada

Pr. Jing Yang
University of California, Moores Cancer Center, USA

Pr. Mikael Pittet
University of Geneva, Ludwig Cancer Center, Switzerland
Pr. Sylvain Meloche
Institute for Research in Immunology and Cancer of the Université de Montréal, Canada

